HMGCR and atherosclerosis: For instance, in atherosclerosis models, berberine inhibits hepatic lipid synthesis enzymes (such as HMG-CoA reductase), promotes reverse cholesterol transport, and reduces serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and oxidized low-density lipoprotein (ox-LDL).